Researchers report an increase in the prescription of weight-loss drugs to children under 12 in the United States. The study finds that use is growing among younger age groups, indicating that anti-obesity medicines are being prescribed earlier than in previous years.
The findings also point to uneven patterns across communities. One outlet highlights that children living in higher-income communities are substantially more likely to receive these prescriptions, suggesting emerging disparities in access or prescribing practices. Other coverage focuses broadly on the overall rise in prescriptions, without disputing that demographic or geographic differences may exist.
Taken together, the reports describe both a trend of expanding pediatric prescribing and potential inequality tied to community income levels. The articles do not provide detailed information on specific drug names, the exact study period, or the clinical criteria used for prescriptions.
